Premier Asset Managment Has Cut Its Gilead Sciences Com (GILD) Holding; Hansberger Growth Investors LP Trimmed Its Hdfc Bank LTD (HDB) Holding

November 14, 2017 - By Hazel Jackson

Premier Asset Managment Llc decreased Gilead Sciences Inc Com (GILD) stake by 92.97% reported in 2017Q2 SEC filing. Premier Asset Managment Llc sold 151,331 shares as Gilead Sciences Inc Com (GILD)’s stock declined 8.05%. The Premier Asset Managment Llc holds 11,450 shares with $810,000 value, down from 162,781 last quarter. Gilead Sciences Inc Com now has $92.20 billion valuation. The stock declined 3.09% or $2.25 reaching $70.6 per share. About 5.79M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since November 14, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Hansberger Growth Investors Lp decreased Hdfc Bank Ltd (HDB) stake by 22.55% reported in 2017Q2 SEC filing. Hansberger Growth Investors Lp sold 22,159 shares as Hdfc Bank Ltd (HDB)’s stock rose 20.33%. The Hansberger Growth Investors Lp holds 76,089 shares with $6.62M value, down from 98,248 last quarter. Hdfc Bank Ltd now has $71.36 billion valuation. The stock declined 0.52% or $0.49 reaching $93.19 per share. About 251,737 shares traded. HDFC Bank Limited (ADR) (NYSE:HDB) has risen 36.23% since November 14, 2016 and is uptrending. It has outperformed by 19.53% the S&P500.

Since June 1, 2017, it had 0 insider purchases, and 2 selling transactions for $5.11 million activity. $4.78M worth of stock was sold by MARTIN JOHN C on Thursday, June 1. Alton Gregg H sold 5,000 shares worth $325,114.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on February, 6. They expect $1.67 EPS, down 36.74% or $0.97 from last year’s $2.64 per share. GILD’s profit will be $2.18B for 10.57 P/E if the $1.67 EPS becomes a reality. After $2.23 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -25.11% negative EPS growth.

Investors sentiment increased to 0.93 in Q2 2017. Its up 0.02, from 0.91 in 2017Q1. It improved, as 78 investors sold GILD shares while 538 reduced holdings. 110 funds opened positions while 462 raised stakes. 938.32 million shares or 0.11% more from 937.32 million shares in 2017Q1 were reported. Amer Money Mngmt Ltd Liability has invested 0.93% in Gilead Sciences, Inc. (NASDAQ:GILD). Blume Capital Management owns 4,500 shares. Baxter Bros has invested 0.12% in Gilead Sciences, Inc. (NASDAQ:GILD). Amica Pension Fund Board Of Trustees, Rhode Island-based fund reported 53,773 shares. 35,386 are owned by Canandaigua Bank & Trust And Tru. American Bankshares has invested 0.46% in Gilead Sciences, Inc. (NASDAQ:GILD). Wellington Shields Cap Mngmt Ltd Co, New York-based fund reported 4,867 shares. Smith Salley Assocs accumulated 24,281 shares. Moreover, Ww Asset Mgmt Inc has 0.31% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 126,548 shares. Intl Investors reported 6.01 million shares. Meridian Counsel holds 0.92% or 21,847 shares in its portfolio. Montecito Bank & Tru, a California-based fund reported 9,476 shares. Signature Mgmt invested 0.1% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). State Board Of Administration Of Florida Retirement Sys has 0.37% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 1.87 million shares. Trilogy Limited Partnership has 0.79% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 334,037 shares.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>